AbbVie (WBO:ABBV) Days Payable : 59.00 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is AbbVie Days Payable?

AbbVie's average Accounts Payable for the three months ended in Dec. 2023 was €3,382 Mil. AbbVie's Cost of Goods Sold for the three months ended in Dec. 2023 was €5,231 Mil. Hence, AbbVie's Days Payable for the three months ended in Dec. 2023 was 59.00.

The historical rank and industry rank for AbbVie's Days Payable or its related term are showing as below:

WBO:ABBV' s Days Payable Range Over the Past 10 Years
Min: 44.22 Med: 72.48 Max: 121.59
Current: 59.2

During the past 13 years, AbbVie's highest Days Payable was 121.59. The lowest was 44.22. And the median was 72.48.

WBO:ABBV's Days Payable is ranked worse than
67.55% of 977 companies
in the Drug Manufacturers industry
Industry Median: 86.3 vs WBO:ABBV: 59.20

AbbVie's Days Payable declined from Dec. 2022 (64.20) to Dec. 2023 (59.00). It may suggest that AbbVie accelerated paying its suppliers.

AbbVie Days Payable Historical Data

The historical data trend for AbbVie's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Days Payable Chart

AbbVie Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

72.66

45.85

52.26

59.06

59.97

AbbVie Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															64.20	67.89	-	-	59.00

Competitive Comparison of AbbVie's Days Payable

For the Drug Manufacturers - General subindustry, AbbVie's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AbbVie's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AbbVie's Days Payable distribution charts can be found below:

* The bar in red indicates where AbbVie's Days Payable falls into.

AbbVie Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

AbbVie's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (2769.696	+	3381.896)	/	2 )	/	18720.555	*	365
=	3075.796					/	18720.555	*	365
=	59.97

AbbVie's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0	+	3381.896)	/	1 )	/	5230.568	*	365 / 4
=	3381.896					/	5230.568	*	365 / 4
=	59.00

AbbVie Days Payable Related Terms

Thank you for viewing the detailed overview of AbbVie's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

AbbVie (WBO:ABBV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (WBO:ABBV) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

ABBV:USA ABBV:Mexico 1ABBV:Italy 4ABd:UK 0QCV:UK 4AB:Germany ABBV:Canada ABBV34:Brazil

Address

1 North Waukegan Road, North Chicago, IL, USA, 60064-6400

Website

http://www.abbvieinvestor.com

AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.